Senores Pharmaceuticals Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting

Senores Pharma announced Q4 & FY26 consolidated results: Revenue up 66% (Q4) to Rs 190 Cr, PAT up 104% to Rs 37 Cr. Full-year revenue surged 65% to Rs 664 Cr, PAT 108% to Rs 122 Cr. Strategic moves include Zoraya & Apnar acquisitions, and a US federal market JV, enhancing pipeline & growth.